PMA P220003S029

Device
PASCAL Precision Transcatheter Valve Repair System
Applicant
Edwards Lifesciences, LLC
PMA number
P220003
Supplement
S029
Product code
NPS
Decision date
2026-10-20
Classification
Cardiovascular
Generic name
Tricuspid valve repair device, percutaneously delivered
Approval order statement
Approval for the Edwards PASCAL Precision Transcatheter Valve Repair System for expanding the indications to include patients with tricuspid regurgitation. This device is indicated for improving quality of life and functional status in patients with symptomatic severe tricuspid regurgitation despite optimal medical therapy who are deemed at intermediate or greater risk for surgery and deemed appropriate for transcatheter edge-to-edge tricuspid valve repair by a multidisciplinary heart team.

Current openFDA PMA Record#

Device
PASCAL Precision Transcatheter Valve Repair System
Applicant
Edwards Lifesciences, LLC
PMA number
P220003
Supplement
S029
Product code
NPS
Generic name
Tricuspid valve repair device, percutaneously delivered
Decision date
2026-10-20
Decision code
APPR
Date received
2026-04-23
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
Approval for the Edwards PASCAL Precision Transcatheter Valve Repair System for expanding the indications to include patients with tricuspid regurgitation. This device is indicated for improving quality of life and functional status in patients with symptomatic severe tricuspid regurgitation despite optimal medical therapy who are deemed at intermediate or greater risk for surgery and deemed appropriate for transcatheter edge-to-edge tricuspid valve repair by a multidisciplinary heart team.